RIGScan CR49 radiolabel data

NEOP (Dublin, Ohio) announced that preliminary Phase III data from Israel, presented at the European Congress for Clinical Oncology in Paris, show that the technique identified tumor in 25 of 27 patients.

In 10 patients, hidden tumor was found that would not otherwise have been detected. Pathology confirmed the diagnoses. ...